Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
MacroGenics
MGNX
$243M
| $623K | ﹤0.01% |
116,540
-23,608
| -17% | -$146K |
|
2527
Pilgrim's Pride
PPC
$6.65B
| $623K | ﹤0.01% |
29,011
+11,588
| +67% | +$261K |
|
2528
Full Truck Alliance
YMM
$10B
| $622K | ﹤0.01% |
100,000
-298,168
| -75% | -$1.92M |
|
2529
Healthcare Services Group
HCSG
$1.61B
| $621K | ﹤0.01% |
41,588
+2,338
| +6% | +$33.9K |
|
|
TBI
2530
Trueblue
TBI
$229M
| $621K | ﹤0.01% |
35,053
+747
| +2% | +$12.7K |
|
2531
PUT
American Tower
AMT
$80.6B
| $621K | ﹤0.01% |
+3,200
| New | +$626K |
|
2532
ArcelorMittal
MT
$54.2B
| $620K | ﹤0.01% |
22,669
-31,146
| -58% | -$856K |
|
2533
RB Global
RBA
$20.7B
| $619K | ﹤0.01% |
10,324
-11,766
| -53% | -$663K |
|
2534
Braze
BRZE
$2.89B
| $619K | ﹤0.01% |
14,142
+10,976
| +347% | +$373K |
|
|
AMPS
2535
DELISTED
Altus Power
AMPS
| $617K | ﹤0.01% |
114,221
+67,686
| +145% | +$334K |
|
|
EB
2536
DELISTED
Eventbrite
EB
| $616K | ﹤0.01% |
64,534
-12,616
| -16% | -$99.2K |
|
2537
Kaiser Aluminum
KALU
$2.68B
| $615K | ﹤0.01% |
8,590
+470
| +6% | +$31.1K |
|
|
MRSN
2538
DELISTED
Mersana Therapeutics
MRSN
| $615K | ﹤0.01% |
7,477
-444
| -6% | -$65K |
|
2539
Genco Shipping & Trading
GNK
$1.13B
| $614K | ﹤0.01% |
43,744
-15,506
| -26% | -$223K |
|
2540
Donnelley Financial Solutions
DFIN
$1.2B
| $612K | ﹤0.01% |
13,449
+336
| +3% | +$14.8K |
|
2541
ATS Corp
ATS
$2.69B
| $612K | ﹤0.01% |
+13,273
| New | +$596K |
|
2542
Coastal Financial
CCB
$651M
| $610K | ﹤0.01% |
16,189
+4,537
| +39% | +$162K |
|
2543
Petco
WOOF
$831M
| $609K | ﹤0.01% |
68,452
-59,342
| -46% | -$546K |
|
2544
abrdn Physical Gold Shares ETF
SGOL
$6.96B
| $609K | ﹤0.01% |
33,130
| – | – |
|
2545
Claros Mortgage Trust
CMTG
$251M
| $607K | ﹤0.01% |
53,550
+6,801
| +15% | +$76.4K |
|
2546
Columbus McKinnon
CMCO
$580M
| $607K | ﹤0.01% |
14,933
-5,468
| -27% | -$202K |
|
2547
Vanguard FTSE All-World ex-US ETF
VEU
$68B
| $606K | ﹤0.01% |
11,135
| – | – |
|
2548
Phreesia
PHR
$698M
| $603K | ﹤0.01% |
19,448
-5,786
| -23% | -$181K |
|
2549
CorMedix
CRMD
$592M
| $603K | ﹤0.01% |
152,046
-11,477
| -7% | -$56.8K |
|
2550
Donegal Group Class A
DGICA
$732M
| $601K | ﹤0.01% |
41,665
-1,647
| -4% | -$24.4K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.